Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers

Business Wire10-29

Achieves 2 Million Jeuveau® Redemptions Anticipates Launch of Club Evolus™, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024 NEWPORT BEACH, Calif., October 29, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2479567406?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XmwZksiIZRK0TuX9SxG6XA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/32764fd33df6f745879439e3f9b9acec","is_english":true,"pubTime":"2024-10-29 20:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2479567406","market":"us","top_or_hot":-1,"title":"Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers","media":"Business Wire","content":"<div>\n<p>Achieves 2 Million Jeuveau® Redemptions\nAnticipates Launch of Club Evolus™, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024\n\nNEWPORT BEACH, Calif., October 29, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/evolus-rewards-patient-loyalty-program-120000277.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-29 20:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/evolus-rewards-patient-loyalty-program-120000277.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Achieves 2 Million Jeuveau® Redemptions\nAnticipates Launch of Club Evolus™, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024\n\nNEWPORT BEACH, Calif., October 29, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/evolus-rewards-patient-loyalty-program-120000277.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4500","symbol_name":"航空公司","start_time":0,"source_url":"https://finance.yahoo.com/news/evolus-rewards-patient-loyalty-program-120000277.html","article_id":"2479567406","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XmwZksiIZRK0TuX9SxG6XA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/32764fd33df6f745879439e3f9b9acec"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479567406","pubTimestamp":1730203200,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Anticipates Launch of Club Evolus, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024. NEWPORT BEACH, Calif., October 29, 2024----Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it recently surpassed one million enrolled consumers and completed the two-millionth Jeuveau redemption in its Evolus Rewards patient loyalty program.\"We are excited to expand our loyalty offering with the upcoming launch of Club Evolus, the industry's first subscription-based consumer membership program from a neurotoxin manufacturer, debuting on November 4th. Powered by the same proprietary digital platform that enhances the practice experience, Club Evolus will offer consumers even more value and convenience.\". Evolus  is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model a","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4500":"航空公司","BK4007":"制药","HA":"夏威夷控股","EOLS":"Evolus Inc.","BK4008":"航空公司"},"translate_title":"Evolus Rewards™患者忠诚度计划注册消费者突破100万","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HA":1,"EOLS":0.9},"content_text":"Achieves 2 Million Jeuveau® Redemptions\nAnticipates Launch of Club Evolus™, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024\n\nNEWPORT BEACH, Calif., October 29, 2024--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it recently surpassed one million enrolled consumers and completed the two-millionth Jeuveau® redemption in its Evolus Rewards™ patient loyalty program.\n\"The achievement of these milestones underscores the success of our strategy to democratize beauty and make aesthetics accessible to a new generation of consumers,\" said David Moatazedi, President and Chief Executive Officer. \"Our easy-to-use, SMS-based loyalty program offers consumers an instant $40 savings on every Jeuveau® treatment, while providing practices with the only co-branded solution to encourage repeat visits. We’re proud of the rapid adoption of this innovative program, which has grown to over 1 million consumers and achieved more than 2 million redemptions.\n\"We are excited to expand our loyalty offering with the upcoming launch of Club Evolus, the industry's first subscription-based consumer membership program from a neurotoxin manufacturer, debuting on November 4th. Powered by the same proprietary digital platform that enhances the practice experience, Club Evolus will offer consumers even more value and convenience.\"\nEvolus Rewards™ was launched in 2020 soon after Jeuveau® was approved by the FDA in 2019. The program offers enrolled patients $40 off Jeuveau® treatments every 90 days at participating providers. The program enhances convenience and ease by delivering a fun, frictionless experience with instant rewards. This approach allows both patients and practices to effortlessly engage with the program.\nEvolus Rewards™ supports the company’s mission of partnering with its customers and driving consumers back to their practices with co-branded reminders and text messages, while attracting the next generation of beauty consumers considering aesthetic injectables. On average, practices participating in Evolus Rewards™ experience significantly higher revenue growth than non-participating practices.\nImportantly, more than half of new entrants to Evolus Rewards™ are millennials or younger. This demographic represents the future of the aesthetics industry and is a highly sought-after audience for providers looking to expand their businesses.\nAbout Evolus, Inc.\nEvolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse™, and the exclusive distributor in Europe of Estyme®, a line of unique injectable hyaluronic acid (HA) gels. These injectable HA gels are currently in the late stages of the regulatory approval process, with plans, upon approval, for a launch starting in 2025. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.\nJeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.Estyme® is a trademark of Symatese Aesthetics S.A.S.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20241029169655/en/\nContacts\nInvestors: Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate CommunicationsPhone: (248) 202-9267Email: ir@evolus.com\nMedia:Email: media@evolus.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479567406"}